Introduction
============

Early studies by Hibert et al. have shown that there are two basic pharmacophore groups common to all five classes of 5-HT~1A~ receptor ligands: a basic nitrogen atom and an aromatic ring with its centre positioned at a distance of 5.2-5.7 Å \[[@B1-molecules-06-00784]\]. Since then several attempts have been made to extend that model, but the large diversity of ligand structures made definition of general interaction modes impossible. In consequence, a search for other pharmacophore groups was limited to single classes or subgroups of ligands \[[@B2-molecules-06-00784],[@B3-molecules-06-00784],[@B4-molecules-06-00784],[@B5-molecules-06-00784]\]. In the case of 1-arylpiperazine derivatives -- the biggest and thoroughly investigated class of 5-HT~1A~ receptor ligands \[[@B6-molecules-06-00784]\] -- an amide moiety \[[@B7-molecules-06-00784]\] or an amide oxygen atom \[[@B8-molecules-06-00784]\] was suggested as a third interaction point; however, the authors developed those models on the basis of a relatively small group of compounds. Extensive CoMFA investigation of a large set of 1-arylpiperazine derivatives has revealed that in this third interaction region different forces, e.g. steric, electrostatic or lipophilic, may influence the ligand-receptor complex formation \[[@B9-molecules-06-00784]\]. Since the role of the amide fragment in ligand-receptor interactions is still unclear systematic structure affinity relationship studies are necessary.

Recently we described the synthesis and pharmacological results concerning new arylpiperazine derivatives with systematic modifications in the amide part, *i.e.* 1-arylpiperazine derivatives of benzoxazinone **1**-**4**, benzoxazolinone **5** and benzoxazolindione **6** \[[@B10-molecules-06-00784]\].

The majority of these compounds have a distinct affinity for 5-HT~1A~ and/or 5-HT~2A~ receptor binding sites. Radioligand binding studies have shown that compounds **1b**, **2a**-**b**, **2d**-**e**, **4b** and **6e**-**f** have a good (K~i~ = 1.25 - 40 nM) and compounds **1a**, **3a**-**b** and **5a**-**b** a moderate (K~i~ = 72-110 nM) affinity for 5-HT~1A~ receptors. The 5-HT~2A~ affinity of the obtained compounds was within a range of K~i~ = 18 - 495 nM. On the other hand Buspirone -- {4-\[4-(2-pyrimidinyl)-1-piperazinyl\]butyl}-8-azaspiro\[4.5\]decane-7,9-dione -- approved as the anxiolytic drug, and its two analogues Ipsapirone and Gepirone bind with high affinity and selectivity to 5-HT~1A~ serotonin receptor sites. Therefore, in order to throw more light on ligand -- 5-HT~1A~ receptor interactions we designed new model 1-phenylpiperazine and 1-(2-pyrimidinyl)piperazine derivatives with systematic structural changes within the terminal amide part.

Results and Discussion
======================

We present in this paper the synthesis of new N-\[3-(4-aryl-1-piperazinyl)propyl\] or N-\[4-(4-aryl-1-piperazinyl)butyl\] derivatives of quinazolidin-4(*3H*)-one (**7a**-**d**), 2-phenyl-2,3-dihydrophthalazine-1,4-dione (**8a**-**d**) and 1-phenyl-1,2-dihydropyridazine-3,6-dione (**9a**-**d**) ([Scheme 1](#molecules-06-00784-f001){ref-type="scheme"}) in which the length of a spacer, arylpiperazine and terminal amide fragment were systematically modified. Preliminary investigation results on affinities of obtained compounds for 5HT~1A~ and 5HT~2A~ receptor sites are also presented.
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Starting materials quinazolidin-4(*3H*)-one (**7**), 2-phenyl-2,3-dihydrophtalazine-1,4-dione (**8**) and 1-phenyl-1,2-dihydropyridazine-3,6-dione (**9**) were obtained according to procedures described in the literature. Quinazolidin-4(*3H*)-one (**7**) was obtained from antranilic acid \[[@B11-molecules-06-00784]\], 2-phenyl-2,3-dihydrophtalazine-1,4-dione (**8**) from ftalic anhydride \[[@B12-molecules-06-00784]\], while 1-phenyl-1,2-dihydropyridazine-3,6-dione (**9**) from maleic anhydride \[[@B13-molecules-06-00784]\].
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Compounds **7a-d**, **8a**-**d**, **9a**-**d** were prepared by a two-step procedure. Alkylation of **7**-**9** with 1-bromo-3-chloropropane (**10**) or 1,4-dibromobutane (**11**) in the presence of K~2~CO~3~ in acetonitrile led to the formation of halogen intermediates **12**, **13**, **16**, **17**, **20** and **21** ([Scheme 2](#molecules-06-00784-f002){ref-type="scheme"}). In the reaction, symmetrically disubstituted derivatives **14**, **15**, **18**, **19**, **22** and **23**, were also formed as byproducts. When in a place of 1-bromo-3-chloropropane (**10**) 1,3-dibromopropane was used, increased yields of the disubstituted derivatives (**14**, **18** and **22**) have been observed. The yields, melting points, and ^1^H-NMR signals observed in the regions characteristic of CH~2~X and CH~2~NC=O protons as well as absorption of the carbonyl group in IR spectra of obtained compounds **12**-**23** are collected in [Table 1](#molecules-06-00784-t001){ref-type="table"}.

The presence of the carbonyl group in the compounds **12**-**15** is confirmed by the absorptions found in the usual carbonyl region at 1658-1680 cm^-1^. The ^1^H-NMR spectra of compounds **12**-**13** display typical signals arising from the methylene hydrogens in the -CH~2~X and -CH~2~NC=O fragments, while disubstituted derivatives **14** and **15** gave ^1^H-NMR spectra in which two equivalent methylene hydrogens have been detected in the -CH~2~NC=O fragment. The above analysis of the ^1^H-NMR and IR spectra indicated that under the applied reaction conditions quinazolidin-4(*3H*)-one (**7**) undergoes N-substitution. Application of the same reaction conditions to alkylation of 2-phenyl-2,3-dihydrophthalazine-1,4-dione (**8**) and 1-phenyl-1,2-dihydropyridazine-3,6-dione (**9**) results in formation of the N-substituted derivatives **16**-**19** and **20**-**23** respectively, in agreement with both our own and literature reports on the structural determination of substituted lactams \[[@B14-molecules-06-00784],[@B15-molecules-06-00784],[@B16-molecules-06-00784],[@B17-molecules-06-00784],[@B18-molecules-06-00784],[@B19-molecules-06-00784],[@B20-molecules-06-00784],[@B21-molecules-06-00784]\].

molecules-06-00784-t001_Table 1

###### 

Reaction yields, physical properties and spectral data of halogen- (**12**, **13**, **16**, **17**, **20** and **21**) and disubstituted derivatives (**14**, **15**, **18**, **19**, **22** and **23**) of quinazolidin-4(*3H*)-one (**7**), 2-phenyl-2,3-dihydrophthalazine-1,4-dione (**8**) and 1-phenyl-1,2-dihydropyridazine-3,6-dione (**9**).

  -----------------------------------------------------------------------------------------
  Comp.\   Yield\   M.p.\     Crystallization\   ^1^H-NMR, δ (ppm)   IR, (cm^-1^)\   
  No.      %        \[°C\]    solvent                                C=O             
  -------- -------- --------- ------------------ ------------------- --------------- ------
  **12**   51       105-107   methanol           3.61, t, 2H         4.20, t, 2H     1665

  **13**   69       86-88     methanol           3.45, t, 2H         4.05, t, 2H     1658

  **14**   5.3      194-196   methanol           \-                  4.23, t, 4H     1672

  **15**   11       223-225   ethanol            \-                  4.10, t, 4H     1680

  **16**   67       80-82     methanol           3.78, t, 2H         4.52, t, 2H     1656

  **17**   49       65-67     methanol           3.52, t, 2H         4.39, t, 2H     1657

  **18**   6.3      145-147   ethanol            \-                  4.61, t, 4H     1669

  **19**   28       241-243   DMF                \-                  4.49, t, 4H     1657

  **20**   65       70-72     acetone            3.70, t, 2H         4.33, t, 2H     1671

  **21**   53       62-65     methanol           3.46, t, 2H         4.20, t, 2H     1670

  **22**   7.1      202-204   methanol           \-                  4.33, t, 4H     1659

  **23**   13       165-167   ethanol            \-                  4.23, t, 4H     1677
  -----------------------------------------------------------------------------------------

Target compounds **7a**-**d**, **8a**-**d**, **9a**-**d** were obtained upon condensation of intermediates **12**, **13**, **16**, **17, 20** or **21** with 1-phenylpiperazine (**24**) or 1-(2-pyrimidinyl)piperazine (**25**), respectively ([Scheme 3](#molecules-06-00784-f003){ref-type="scheme"}).
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Reactions were carried out in acetonitrile in the presence of anhydrous K~2~CO~3~. Reaction yields and the properties of the obtained compounds are presented in the Experimental section of the paper. The mass spectra of the compounds **7a**-**d**, **8a**-**d**, **9a**-**d** ([Scheme 4](#molecules-06-00784-f004){ref-type="scheme"}) generally show the presence of molecular ions of weak intensity.
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The base peaks of the investigated compounds mainly correspond to \[CH~2~=NR~2~\]^+^ ion formation: m/z=175; m/z=177. This is in agreement with the general patterns observed for alkylamine fragmentation \[[@B22-molecules-06-00784],[@B23-molecules-06-00784]\]. In case of derivatives **7a**-**b**, **8a**-**b**, **9a**-**b**, with a three member spacer chain, we find that fragmentation leads to fragments with m/z=187, m/z=279 and m/z=229 respectively, which are consistent with the behaviour of alkyl substituted lactams in mass spectroscopy \[[@B23-molecules-06-00784]\]

Biological activity
===================

Preliminary investigations of the affinity of the obtained compounds **7a**-**d**, **8a**-**d**, **9a**-**d** towards 5-HT~1A~ and 5-HT~2A~ receptors were performed using compound **8c** and **9c**. Affinities were assessed *in vitro* on the basis of their ability to displace \[^3^H\]-8-OH-DPAT \[8-hydroxy-2-(n-propylamino)tetraline\] and \[^3^H\]-ketanserin, respectively. Radioligand binding experiments were conducted in the rat hippocampus for 5-HT~1A~ receptors and in the cortex for 5-HT~2A~ receptors according to published procedures \[[@B24-molecules-06-00784]\]. The results showed that compound **9c** has good affinity for 5-HT~1A~ receptors (K~i~ = 19 ± 1 nM), better than that of compound **8c** (K~i~ = 119 ± 8 nM), while both compounds have moderate affinity for 5-HT~2A~ receptors (K~i~ = 309 ± 1 nM for **8c** and K~i~ = 409 ± 17 nM for **9c**). Full experimental results on the affinities of all the obtained compounds **7a-d**, **8a**-**d**, **9a**-**d** for serotonin 5-HT~1A~/5-HT~2A~ receptor sites will be presented soon in an appropriate pharmaceutical journals.

Experimental
============

General
-------

Elemental analyses were performed on a Perkin-Elmer 2400 analyser. EI mass spectra were carried out with a Varian MAT 112 spectrometer at 70 eV. The ^1^H-NMR spectra were recorded in deuterochloroform with a Tesla 487C (80 MHz) spectrometer and using tetramethylsilane (TMS) as an internal standard; the chemical shifts are reported in ppm (δ); coupling constants were taken from the expanded spectrum. IR spectra were recorded on a Bio-Rad FTS-175C spectrophotometer in KBr pellets. Melting points were determined in a Boetius apparatus and are uncorrected. For biological experiments, free bases **7a**-**d**, **8a**-**d**, **9a**-**d** were converted into their hydrochloride salts and their molecular formulas and molecular weights were established on the basis of an elemental analysis.

General procedure for preparation of derivatives **12**, **13**, **16**, **17**, **20** and **21**
--------------------------------------------------------------------------------------------------

A mixture of the lactam **7** or **8** or **9** (0.1 mole), the appropriate 1-bromo-3-chloropropane (**10**) (0.12 mole) or 1,4-dibromobutane (**11**) (0.12 mole), powdered K~2~CO~3~ (20.7 g, 0.15 mole) and a catalytic amount of KI in acetonitrile (200 mL) was stirred and refluxed 24 h ([Scheme 2](#molecules-06-00784-f002){ref-type="scheme"}). The cold reaction mixture was filtered and the filter cake washed with cold acetonitrile (20 mL). The combined filtrates were evaporated to dryness and the residue was purified by recrystallisation. Reaction yields and physical properties of the obtained compounds **12**, **13**, **16**, **17**, **20** and **21** are given in [Table 1](#molecules-06-00784-t001){ref-type="table"}. From the dry filter cake, after suspending in water, byproducts **14**, **15**, **18**, **19**, **22** and **23** were isolated with moderate yields. Reaction yields and physical properties of compounds **14**, **15**, **18**, **19**, **22** and **23** are collected in [Table 1](#molecules-06-00784-t001){ref-type="table"}.

General procedure for the preparation of compounds **7a**-**d**, **8a**-**d** and **9a**-**d**
----------------------------------------------------------------------------------------------

A mixture of the corresponding chloro derivative (**12**, **16**, **20**) (0.01 mole), arylpiperazine (**24**, **25**) (0.01 mole), powdered K~2~CO~3~ (4.14 g, 0.03 mole) and catalytic amount of KI in acetonitrile (30 mL) was stirred for 48 h at 50-60° ([Scheme 3](#molecules-06-00784-f003){ref-type="scheme"}). When in place of the chloro derivatives (**12**, **16**, **20**) a bromo derivative (**13**, **17**, **21**) (0.01 mole) was used, the reaction mixture was stirred at 50-60 ° for 24 h. The inorganic precipitate was filtered off, the filtrate was evaporated, and the residue was recrystallised from the appropriate solvent.

General procedure for the preparation of hydrochlorides
-------------------------------------------------------

Free bases **7a**-**d**, **8a**-**d** and **9a**-**d** were converted into their hydrochlorides by dissolving the corresponding base in acetone (10mL/g) and treating with ethanol saturated with HCl. The precipitate was filtered off and washed with acetone. Some of the hydrochlorides were additionally purified by recrystallisation.

3-\[3-(4-phenyl-1-piperazinyl)propyl\]-quinazolidin-4(3H)-one *(**7a**)*
------------------------------------------------------------------------

Base **7a** was obtained in 64% yield, m.p. 119-121°C (methanol); ^1^H-NMR: δ 1.92-2.17 (m, 2H, CH~2~*CH~2~*CH~2~), δ 2.35-2.66 (m, 6H, *CH~2~*N(CH~2~)~2~ and CH~2~N*(CH~2~)~2~*), δ 3.10-3.24 (m, 4H, *(CH~2~)~2~*NAr), δ 4.12 (t, 2H, *CH~2~*NC=O, J=6.6 Hz), δ 8.14 (s, 1H, *CH*=N), δ 6.87-8.38 (m, 9H~Ar~); MS: m/z (I%); M 348 (92), 187 (100) 175 (56); Hydrochloride m.p. 210-213°C (acetone-methanol 10:1); *Anal*. Calcd. for C~21~H~24~N~4~O•2HCl•1.5H~2~O (448.40): C, 56.25; H, 6.52; N, 12.50; Found: C, 55.96; H, 6.37; N, 12.58.

3-{3-\[4-(2-pyrimidinyl)-1-piperazinyl\]propyl}-quinazolidin-4(3H)-one *(**7b**)*
---------------------------------------------------------------------------------

Base **7b** was obtained in 71% yield, m.p. 102-103°C (acetone); ^1^H-NMR: δ 1.94-2.16 (m, 2H, CH~2~*CH~2~*CH~2~), δ 2.34-2.59 (m, 6H, *CH~2~*N(CH~2~)~2~ and CH~2~N*(CH~2~)~2~*), δ 3.72-3.91 (m, 4H, *(CH~2~)~2~*NAr), δ 4.14 (t, 2H, *CH~2~*NC=O, J=6.6 Hz), δ 6.48 (t, 1H, 5H~Pyrim~, J=4.7 Hz), δ 8.16 (s, 1H, *CH*=N), δ 8.31 (d, 2H, 4H~Pyrim~ and 6H~Pyrim~, J=4.7 Hz), δ 7.44-8.38 (m, 4H~Ar~); MS: m/z (I%); M 350 (5),187 (100), 177 (30); Hydrochloride m.p. 224-227°C (acetone-ethanol 10:1); *Anal*. Calcd. for C~19~H~22~N~6~O•2HCl (423.35): C, 53.91; H, 5.71; N, 19.85; Found: C, 53.99; H, 5.77; N, 19.76.

3-\[4-(4-phenyl-1-piperazinyl)butyl\]-quinazolidin-4(3H)-one *(**7c**)*
-----------------------------------------------------------------------

Base **7c** was obtained in 61% yield, m.p. 139-141°C (methanol); ^1^H-NMR: δ 1.56-2.03 (m, 4H, CH~2~*CH~2~CH~2~*CH~2~), δ 2.34-2.66 (m, 6H, *CH~2~*N(CH~2~)~2~ and CH~2~N*(CH~2~)~2~*) , δ 3.12-3.25 (m, 4H, *(CH~2~)~2~*NAr), δ 4.05 (t, 2H, *CH~2~*NC=O, J=6.6 Hz), δ 8.03 (s, 1H, *CH*=N), δ 6.81-8.37 (m, 9H~Ar~); MS: m/z (I%); M 362 (69), 175 (100); Hydrochloride m.p. 216-219°C (acetone-ethanol 10:1); *Anal*. Calcd. for C~22~H~26~N~4~O•2HCl (435.40): C, 60.69; H, 6.48; N, 12.87; Found: C, 60.42; H, 6.58; N, 12.60.

3-{4-\[4-(2-pyrimidinyl)-1-piperazinyl\]butyl}-quinazolidin-4(3H)-one *(**7d**)*
--------------------------------------------------------------------------------

Base **7d** was obtained in 70% yield, m.p. 95-97°C (acetone); ^1^H-NMR: δ 1.62-2.01 (m, 4H, CH~2~*CH~2~CH~2~*CH~2~), δ 2.34-2.54 (m, 6H, *CH~2~*N(CH~2~)~2~ and CH~2~N*(CH~2~)~2~*), δ 3.74-3.96 (m, 4H, *(CH~2~)~2~*NAr), δ 4.05 (t, 2H, *CH~2~*NC=O, J=6.6 Hz), δ 6.47 (t, 1H, 5H~Pyrim~, J=4.7 Hz), δ 8.04 (s, 1H, *CH*=N), δ 8.30 (d, 2H, 4H~Pyrim~ and 6H~Pyrim~, J=4.7 Hz), δ 7.50-8.37 (m, 4H~Ar~); MS: m/z (I%); M 364 (21), 177 (100); Hydrochloride: m.p. 192-195°C (2-propanol-acetone 1:1); *Anal*. Calcd. for C~20~H~24~N~6~O•HCl•0.5H~2~O (409.92): C, 58.60; H, 6.39; N, 20.50; Found: C, 58.89; H, 6.64; N, 20.25.

3-\[3-(4-phenyl-1-piperazinyl)propyl\]-2-phenyl-2,3-dihydrophthalazine-1,4-dione *(**8a**)*
-------------------------------------------------------------------------------------------

Base **8a** was obtained in 69% yield, m.p. 54-56°C (methanol); ^1^H-NMR: δ 1.99-2.26 (m, 2H, CH~2~*CH~2~*CH~2~), δ 2.56-2.75 (m, 6H, *CH~2~*N(CH~2~)~2~ and CH~2~N*(CH~2~)~2~*), δ 3.11-3.28 (m, 4H, *(CH~2~)~2~*NAr), δ 4.45 (t, 2H, *CH~2~*NC=O, J=6.6 Hz), δ 6.91-8.55 (m, 14H~Ar~); MS: m/z (I%); M 440 (10), 279 (6), 175 (100); Hydrochloride m.p. 215-218 °C (ethanol); *Anal*. Calcd. for C~27~H~28~N~4~O~2~•HCl•0.5H~2~O (486.02): C, 66.73; H, 6.22; N, 11.53; Found: C, 66.62; H, 6.19; N, 11.50.

3-{3-\[4-(2-pyrimidinyl)-1-piperazinyl\]propyl}-2-phenyl-2,3-dihydrophthalazine-1,4-dione *(**8b**)*
----------------------------------------------------------------------------------------------------

Base **8b** was obtained in 63% yield, m.p. 128-130°C (acetone); ^1^H-NMR: δ 1.97-2.27 (m, 2H, CH~2~*CH~2~*CH~2~), δ 2.45-2.72 (m, 6H, *CH~2~*N(CH~2~)~2~ and CH~2~N*(CH~2~)~2~*), δ 3.78-3.93 (m, 4H, *(CH~2~)~2~*NAr), δ 4.44 (t, 2H, *CH~2~*NC=O, J=6.6 Hz), δ 6.48 (t, 1H, 5H~Pyrim~, J=4.7 Hz), δ 8.30 (d, 2H, 4H~Pyrim~ and 6H~Pyrim~, J=4.7 Hz), δ 7.34-8.55 (m, 9H~Ar~); MS: m/z (I%); M 442 (16), 279 (56), 177 (100); Hydrochloride m.p. 226-229°C (acetone-ethanol 1:3); *Anal*. Calcd. for C~25~H~26~N~6~O~2~•2HCl•0.5H~2~O (524.45): C, 57.26; H, 5.57; N, 16.02; Found: C, 57.34; H, 5.62; N, 15.92.

3-\[4-(4-phenyl-1-piperazinyl)butyl\]-2-phenyl-2,3-dihydrophthalazine-1,4-dione *(**8c**)*
------------------------------------------------------------------------------------------

Base **8c** was obtained in 73% yield, m.p. 111-113 °C (ethanol); ^1^H-NMR: δ 1.72-2.03 (m, 4H, CH~2~*CH~2~CH~2~*CH~2~), δ 2.41-2.70 (m, 6H, *CH~2~*N(CH~2~)~2~ and CH~2~N*(CH~2~)~2~*), δ 3.14-3.29 (m, 4H, *(CH~2~)~2~*NAr), δ 4.39 (t, 2H, *CH~2~*NC=O, J=6.6 Hz), δ 6.86-8.47 (m, 14H~Ar~); MS: m/z (I%); M 454 (7), 175 (100); Hydrochloride m.p. 179-183°C (acetone-ethanol 10:1); *Anal*. Calcd. for C~28~H~30~N~4~O~2~•HCl•H~2~O (491.03): C, 66.07; H, 6.13; N, 11.00; Found: C, 66.29; H, 6.50; N, 10.83.

3-{4-\[4-(2-pyrimidinyl)-1-piperazinyl\]butyl}-2-phenyl-2,3-dihydrophthalazine-1,4-dione *(**8d**)*
---------------------------------------------------------------------------------------------------

Base **8d** was obtained in 58% yield, m.p. 154-156°C (methanol); ^1^H-NMR: δ 1.72-1.99 (m, 4H, CH~2~*CH~2~CH~2~*CH~2~), δ 2.41-2.65 (m, 6H, *CH~2~*N(CH~2~)~2~ and CH~2~N*(CH~2~)~2~*), δ 3.77-3.91 (m, 4H, *(CH~2~)~2~*NAr), δ 4.39 (t, 2H, *CH~2~*NC=O, J=6.6 Hz), δ 6.48 (t, 1H, 5H~Pyrim~, J=4.7 Hz), δ 8.32 (d, 2H, 4H~Pyrim~ and 6H~Pyrim~, J=4.7 Hz), δ 7.34-8.55 (m, 9H~Ar~); MS: m/z (I%); M 456 (5), 177 (100); Hydrochloride m.p. 207-209°C (acetone-ethanol 10:1); *Anal*. Calcd. for C~26~H~28~N~6~O~2~•2HCl•H~2~O (547.48): C, 57.04; H, 5.89; N, 15.35; Found: C, 57.31; H, 5.98; N, 15.26.

2-\[3-(4-phenyl-1-piperazinyl)propyl\]-1-phenyl-1,2-dihydropyridazine-3,6-dione *(**9a**)*
------------------------------------------------------------------------------------------

Base **9a** was obtained in 74% yield, m.p. 97-99°C (acetone); ^1^H-NMR: δ 1.88-2.09 (m, 2H, CH~2~*CH~2~*CH~2~), δ 2.44-2.69 (m, 6H, *CH~2~*N(CH~2~)~2~ and CH~2~N*(CH~2~)~2~*), δ 3.12-3.26 (m, 4H, *(CH~2~)~2~*NAr), δ 4.25 (t, 2H, *CH~2~*NC=O, J=6.6 Hz), δ 6.85-7.74 (m, 12H~Ar~); MS: m/z (I%); M 390 (22), 229 (14), 175 (100); Hydrochloride m.p. 219-221°C (acetone-ethanol 10:1); *Anal*. Calcd. for C~23~H~26~N~4~O~2~•HCl•H~2~O (444.96): C, 62.08; H, 6.57; N, 12.59; Found: C, 62.13; H, 6.63; N, 12.33.

2-{3-\[4-(2-pyrimidinyl)-1-piperazinyl\]propyl}-1-phenyl-1,2-dihydroppyridazine-3,6-dione *(**9b**)*
----------------------------------------------------------------------------------------------------

Base **9b** was obtained in 72% yield, m.p. 152-154°C (methanol); ^1^H-NMR: δ 1.84-2.06 (m, 2H, CH~2~*CH~2~*CH~2~), δ 2.43-2.62 (m, 6H, *CH~2~*N(CH~2~)~2~ and CH~2~N*(CH~2~)~2~*), δ 3.75-3.93 (m, 4H, *(CH~2~)~2~*NAr), δ 4.25 (t, 2H, *CH~2~*NC=O, J=6.6 Hz), δ 6.48 (t, 1H, 5H~Pyrim~, J=4.7 Hz), δ 6.99-7.74 (m, 7H~Ar~), 8.30 (d, 2H, 4H~Pyrim~ and 6H~Pyrim~, J=4.7 Hz); MS: m/z (I%); M 392 (100), 229 (64), 177 (85); Hydrochloride m.p. 219-221°C (acetone-ethanol 10:1); *Anal*. Calcd. for C~21~H~24~N~6~O~2~•2HCl (465.38): C, 54.20; H, 5.63; N, 18.06; Found: C, 54.27; H, 5.74; N, 17.80.

2-\[4-(4-phenyl-1-piperazinyl)butyl\]-1-phenyl-1,2-dihydropyridazine-3,6-dione *(**9c**)*
-----------------------------------------------------------------------------------------

Base **9c** was obtained in 71% yield, m.p. 91-93°C (methanol-H~2~O 4:1); ^1^H-NMR: δ 1.62-1.94 (m, 4H, CH~2~*CH~2~CH~2~*CH~2~), δ 2.37-2.66 (m, 6H, *CH~2~*N(CH~2~)~2~ and CH~2~N*(CH~2~)~2~*), δ 3.13-3.27 (m, 4H, *(CH~2~)~2~*NAr), δ 4.20 (t, 2H, *CH~2~*NC=O, J=6.6 Hz), δ 6.86-7.72 (m, 12H~Ar~); MS: m/z (I%); M 404 (9), 175 (100); Hydrochloride m.p.199-202°C (methanol); *Anal*. Calcd. for C~24~H~28~N~4~O~2~•HCl (440.97): C, 65.37; H, 6.63; N, 12.71; Found: C, 65.12; H, 6.35; N, 12.53.

2-{4-\[4-(2-pyrimidinyl)-1-piperazinyl\]butyl}-1-phenyl-1,2-dihydropyridazine-3,6-dione *(**9d**)*
--------------------------------------------------------------------------------------------------

Base **9d** was obtained in 66% yield, m.p. 104-106 °C (acetone); ^1^H-NMR: δ 1.56-1.81 (m, 4H, CH~2~*CH~2~CH~2~*CH~2~), δ 2.44-2.58 (m, 6H, *CH~2~*N(CH~2~)~2~ and CH~2~N*(CH~2~)~2~*), δ 3.75-3.91 (m, 4H, *(CH~2~)~2~*NAr), δ 4.20 (t, 2H, *CH~2~*NC=O, J=6.6 Hz), δ 6.48 (t, 1H, 5H~Pyrim~, J=4.7 Hz), δ 6.97-7.74 (m, 7H~Ar~), δ 8.30 (d, 2H, 4H~Pyrim~ and 6H~Pyrim~, J=4.7 Hz); MS: m/z (I%); M 406 (33), 177 (100); Hydrochloride m.p. 203-205 °C (methanol); *Anal*. Calcd. for C~22~H~26~N~6~O~2~•HCl•H~2~O (460.96): C, 57.32; H, 6.34; N, 18.23; Found: C, 57.49; H, 6.19; N, 18.19.

*Sample Availability:* Available from the authors.
